Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese

[1]  U. Panzer,et al.  Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. , 2014, Journal of the American Society of Nephrology : JASN.

[2]  J. Wetzels,et al.  Treatment of idiopathic membranous nephropathy , 2013, Nature Reviews Nephrology.

[3]  V. Tesar,et al.  Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  E. Messias,et al.  Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.

[5]  Y. Kim,et al.  Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy , 2013, PloS one.

[6]  D. Salant.  Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy? , 2013, Journal of the American Society of Nephrology : JASN.

[7]  B. Rovin,et al.  IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression , 2013, Modern Pathology.

[8]  H. Debiec,et al.  Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. , 2012, Journal of the American Society of Nephrology : JASN.

[9]  U. Panzer,et al.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.

[10]  J. Wetzels,et al.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[11]  Ming-hui Zhao,et al.  Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  David M. Beck,et al.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[13]  David M. Beck,et al.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[14]  D. Salant,et al.  Anti-phospholipase A2 receptor antibody in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[15]  H. Debiec,et al.  PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.

[16]  David M. Beck,et al.  Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[17]  克治 桑門.  海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[18]  R. Glassock.  The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  M. Prunotto,et al.  Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. , 2010, Journal of the American Society of Nephrology : JASN.

[20]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[21]  T. Rispens,et al.  Immunoglobulin G4: an odd antibody , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[22]  T. Shibata,et al.  Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. , 2005, Kidney international.

[23]  N. Yorioka,et al.  Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. , 2004, Kidney international.

[24]  W. Baldwin,et al.  Non‐Complement‐ and Complement‐Activating Antibodies Synergize to Cause Rejection of Cardiac Allografts , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[25]  A. Komatsuda,et al.  Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  S. Goshima,et al.  Pathologic findings of initial biopsies reflect the outcomes of membranous nephropathy. , 2004, Kidney international.

[27]  S. Goshima,et al.  The short- and long-term outcomes of membranous nephropathy treated with intravenous immune globulin therapy , 1999 .

[28]  A. Komatsuda,et al.  IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. , 1997, Kidney international.